MYDGF and metabolic dysfunction-associated steatotic liver disease: Recent data have revealed that myeloid cell-derived growth factor (MYDGF) alleviates NAFLD and inflammation in a manner involving IKKβ/NF-κB signaling, and serves as a factor involved in the crosstalk between the liver and bone marrow that regulates liver fat metabolism (77).